This website was created to share the inspiring story of Paul Kraus with newly diagnosed mesothelioma patients and their loved ones. In the summer of 1997, Paul Kraus was diagnosed with mesothelioma and given only a few months to live.  Rather than give up, Paul spoke with doctors from all over the world and with their help created a unique treatment plan.  This plan involved the use of various types of therapies.  Focused on recovering his health and outliving his prognosis, Paul followed the advice of his physicians carefully.


Paul stayed with his treatment plan and today he has outlived his prognosis by nearly two decades.  Many mesothelioma patients were interested in what Paul did and so he wrote this book, “Surviving Mesothelioma and Other Cancers: A Patient’s Guide,” to explain his philosophy of healing and the decisions that he made.  This book discusses the approaches and healing philosophies Paul used in his own journey to survive mesothelioma.


Request your free copy by clicking here.

Mesothelioma Breaking News

  • Lung Cancer or Mesothelioma? BAP1 May be Key

    31155911_lady researcherA team of top mesothelioma researchers say there may be a better way to distinguish malignant mesothelioma from lung cancer (carcinoma). While lung carcinoma and pleural mesothelioma are both malignancies, mesothelioma can grow and spread differently and may respond better to different types of treatment than lung carcinoma. Unfortunately, the two cancers can be difficult to differentiate from one another using current ...
  • Novel Mesothelioma Treatment is Based on Marine-Derived Compound

    Lab TechA new drug based on a compound derived from sea creatures may make an effective second-line treatment for patients with malignant pleural mesothelioma. Most people who are diagnosed with mesothelioma will be treated with a chemotherapy combination that includes pemetrexed (Alimta) and the platinum-based drug cisplatin. But, although pemetrexed/cisplatin is the gold standard for treating the asbestos cancer, it is only moderately effective. For ...
  • Investigational Mesothelioma Drug to be Tested in Human Patients

    16142723_woman patient2Researchers in Japan say they are about to start the first clinical trial of an investigational mesothelioma drug that has shown promise in animals. The drug is a monoclonal antibody called YS110 that targets a protein called CD26. CD26 is believed to play a role in mesothelioma tumor growth and invasion and in the process of cell death known as ...
What is mesothelioma

What is Mesothelioma

Learn about the types of mesothelioma - pleural and peritoneal, statistics, and how mesothelioma is diagnosed.



Causes of mesothelioma

Causes of Mesothelioma

Learn about the different types of asbestos and where this carcinogenic mineral can be found even today.



Mesothelioma Legal Resources

Mesothelioma Legal Resources

Learn about the compensation available to mesothelioma victims and how to identify reputable law firms.



Navigation